Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

NCT07101094 · clinicaltrials.gov ↗

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: xanomeline and trospium chloride (X/T) therapy

Sponsor

Bristol-Myers Squibb